Mcrpc Survival Rates
214 men with mCRPC and PD after 24 wk Abiraterone - 145 chemotherapy-naïve - 69 post chemotherapy Median duration of therapy with Enza 57m Median. Median overall survival for the total cohort was 255 months B vs 218 months W hazard ratio HR081 p 008. Overall Survival And Second Primary Malignancies In Men With Metastatic Prostate Cancer One formal interim analysis was planned after approximately 50 of. Mcrpc survival rates . Five-year survival for prostate cancer shows an unusual pattern with age. Population-based survival derived from cancer registries differs in several important ways from survival derived in clinical trial settings. The section on Cohort Definition describes various approaches to defining which years of diagnosis are included in order to provide more up-to-date estimates of survival. Among over 100 patients in the single-center analysis 3-year cancer-specific survival rates were 880 for those treated with docetaxel first as compared with 641 for those w